Search clinical trials for: T cell leukemia/lymphoma

Total 498716 results

First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

Neuroendocrine Tumors
Malaghan Institute of Medical Research
Wellington Zhaotai Therapies Limited; BioOra Limited

Not yet recruiting

A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma (ENABLE-2)

Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Non-Hodgkin Lymphoma

New Zealand
Tang-Du Hospital

Recruiting

Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

Small Cell Lung Cancer (SCLC)

China
Addario Lung Cancer Medical Institute

Not yet recruiting

Small Cell Lung Cancer Community Engagement to Eliminate Research Disparities (SUCCEED)

Small-cell Lung Cancer
Princess Maxima Center for Pediatric Oncology
EUSA Pharma, Inc.

Not yet recruiting

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma (DBPilot)

Neuroblastoma

Netherlands
Chengdu Zenitar Biomedical Technology Co., Ltd

Recruiting

A Phase IIa Clinical Study of Puesta Mesylate for Injection in Patients With T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL) | Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

China
Xuanwu Hospital, Beijing
Bioray Laboratories

Not yet recruiting

Universal CAR-T Cells in Patients With Refractory Autoimmune Diseases of the Nervous System.

Multiple Sclerosis | Neuromyelitis Optica Spectrum Disorders | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Myasthenia Gravis, Generalized

China
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma

Oral Tongue Squamous Cell Carcinoma

United States
Tang-Du Hospital

Not yet recruiting

A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC

Resectable Non-small Cell Lung Cancer
Chinese PLA General Hospital

Not yet recruiting

Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis (LN)

Lupus Nephritis
Assistance Publique Hopitaux De Marseille

Not yet recruiting

Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma (MEPENDAX)

Ependymoma | Medulloblastoma
University Health Network, Toronto
Myeloma Canada; The Leukemia and Lymphoma Society of Canada

Not yet recruiting

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

Lymphoma, B-Cell | Multiple Myeloma | B Cell Lymphoma | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma Progression | Multiple Myeloma Stage III | Aggressive Lymphoma
Region Skane
Swedish Lung Cancer Study Group

Recruiting

EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study (ERIS)

Non-Small Cell Lung Cancer

Sweden
Merck Sharp & Dohme LLC

Not yet recruiting

A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Metastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma
Brigham and Women's Hospital
Medical University of South Carolina; M.D. Anderson Cancer Center; Massachusetts... and other collaborators

Recruiting

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Multiple Myeloma | Acute Kidney Injury | Light Chain Nephropathy

United States
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation
Shenzhen TargetRx, Inc.
Sir Run Run Shaw Hospital

Not yet recruiting

TGRX-1942 Chinese Phase I for Advanced Solid Tumor and/or Relapsed/Refractory Hematologic Malignancies

Non Small Cell Lung Cancer | Advanced Solid Tumor | Hematologic Malignancy
Washington University School of Medicine
Pfizer; National Comprehensive Cancer Network; Rapid Novor

Not yet recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance Using Peripheral Blood Clonotypic Mass Spectrometry

Multiple Myeloma

United States
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

A Clinical Study of SHR-9539 in Patients With Multiple Myeloma

Multiple Myeloma

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Acute Myeloid Leukemia

China
UNC Lineberger Comprehensive Cancer Center

Not yet recruiting

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel (PANGEA)

Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Basal Cell Neoplasm

United States
Applied Biology, Inc.
Follea International Limited

Not yet recruiting

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

Androgenetic Alopecia | Female Pattern Baldness
Jin Ying

Recruiting

A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer

Small Cell Lung Cancer Limited Stage

China
Chengdu Zenitar Biomedical Technology Co., Ltd

Not yet recruiting

Puesta Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma (RRMM)

China
Rita Assi

Not yet recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

B-cell Lymphoma | Refractory Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin Lymphoma | Relapsed Hodgkin Lymphoma

United States
University Medical Center Groningen
Dutch Cancer Society

Not yet recruiting

IMPT Dose Escalation for NSCLC (HyDose) (HyDose)

Carcinoma, Non-Small-Cell Lung

Netherlands
Iovance Biotherapeutics, Inc.

Not yet recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Endometrial Cancer
Tcelltech Inc.
Beijing Tiantan Hospital

Not yet recruiting

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

High-grade Glioma | WHO Grade Ⅳ Glioma

China
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

Acute Lymphoblastic Leukemia, Adult | Philadelphia Chromosome Negative ALL

China
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Philadelphia Positive Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Adult

China
Shanghai Chest Hospital

Not yet recruiting

Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC

Non-Small-Cell Lung Cancer
Chongqing University Cancer Hospital

Recruiting

Efficacy of Almonertinib Combined With Upfront Stereotactic Ablative Body Radiotherapy to Residual Primary Lung Lesions in Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Bristol-Myers Squibb

Not yet recruiting

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Healthy Volunteers | Anemia, Sickle Cell

United States
University Medical Center Groningen

Not yet recruiting

Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET ([18F]-olaparib)

Head and Neck Squamous Cell Carcinoma (HNSCC)

Netherlands
Chinese PLA General Hospital
Peking University; EdiGene Inc.

Recruiting

TCR Reserved and Power3 Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Acute Lymphocytic Leukemia

China
Mayo Clinic

Not yet recruiting

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Recurrent... and other conditions

United States
University Medical Center Groningen

Not yet recruiting

Bleeding in Multiple Myeloma (BiMM)

Multiple Myeloma
Christian Schmidt, MD
Johannes Gutenberg University Mainz

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma (CARMAN)

Mantle Cell Lymphoma

Germany
University of California, San Diego
Kyoto University; Sumitomo Pharma America, Inc.

Recruiting

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) (CT1-DAP001)

PD - Parkinson's Disease

United States
Peking Union Medical College Hospital

Recruiting

Glofitamab in Chinese Patients With R/R DLBCL

DLBCL - Diffuse Large B Cell Lymphoma

China
Nantes University Hospital

Not yet recruiting

Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients (BREATHE)

Carcinoma, Non-Small-Cell Lung | Small Cell Lung Carcinoma | Lung Cancer | Metastatic Lung Cancer
Yunpeng Liu
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Small Cell Lung Cancer

Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (ACCLAIM)

NSCLC | PD-1

China
Second Affiliated Hospital of Guangzhou Medical...

Not yet recruiting

Stem Cell Derived Exome for Treatment of Diabetic Foot

Diabetic Foot | Stem Cell

China
Pfizer

Not yet recruiting

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

Relapsed and Refractory Multiple Myeloma (RRMM)
St. Jude Children's Research Hospital

Not yet recruiting

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

High-risk Neuroblastoma

United States
Veerle Ruijters
ZonMw: The Netherlands Organisation for Health Research and Development; Curium...

Not yet recruiting

FET-PET-Guided Management of Pseudoprogression in Glioblastoma (FET-POPPING)

Glioblastoma | Radionecrosis of Brain

Netherlands
Wake Forest University Health Sciences
Brookdale University Hospital Medical Center; Atrium Health Levine Cancer Institute

Not yet recruiting

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Myeloproliferative Neoplasm

United States
Adicet Therapeutics

Not yet recruiting

A Phase 1/2 Trial of ADI-270 in ccRCC

Clear Cell Renal Cell Carcinoma
Anhui Provincial Hospital

Recruiting

Radiotherapy to All Residual Lesions After Chemoimmunotherapy

Extensive-stage Small Cell Lung Cancer

China

Search clinical trials for: T cell leukemia/lymphoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations